Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

PuraPharm Corp. Ltd. (1498) Stock Price & Analysis

1 Followers

1498 Stock Chart & Stats

HK$0.23-HK$0.01(-4.60%)
At close: 4:00 PM GMT+8
HK$0.225HK$0.25HK$0.275Aug 17Sep 2Sep 14Sep 29Oct 12Oct 26Nov 9
Day’s Range
HKD 0.22 - HKD 0.24
52-Week Range
HKD 0.21 - HKD 0.41
Previous Close
HKD 0.24
Volume
N/A
Average Volume (3M)
26.43K
Market Cap
HKD 127.85M
Enterprise Value
HKD 517.12M
Total Cash (Recent Filing)
HKD 12.23M
Total Debt (Recent Filing)
HKD 370.62M
Price to Earnings (P/E)
―
Beta
0.25
Next Earnings
Mar 31, 2027 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
May 31, 2017
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Integrated Chinese Medicine Business

The company operates across product development, manufacturing, commercialization, and distribution, giving it multiple ways to participate in the Chinese medicine value chain. Its access to clinics, hospitals, pharmacies, and other channels provides an established platform for future product sales.

Gross Profitability

A gross margin near 53% indicates that the underlying products retain meaningful value after direct costs, even though the company remains loss-making overall. This provides a base from which improved operating discipline or renewed revenue growth could support better profitability over time.

Positive Cash Generation

Positive operating and free cash flow across four consecutive years is an important financial strength because it shows the business has generated cash despite reported losses. This can help fund operations and investment internally, although the durability of that cash generation remains uneven.

Bears Say

Persistent Losses And Revenue Contraction

Repeated EBIT and net losses, combined with multi-year revenue contraction, indicate that the business has not yet converted its gross profitability into sustainable earnings. Shrinking sales also limit operating leverage and make a durable recovery in profitability less certain.

High Leverage And Negative Returns

Elevated leverage alongside materially negative returns on equity increases financial risk and reduces flexibility in allocating capital. A declining equity base can make future losses more damaging, while debt obligations may constrain the company’s ability to invest through a prolonged operating recovery.

Volatile Cash Conversion

Although recent cash flow has been positive, the sharp 2025 decline in free cash flow and the negative result in 2021 show that cash generation is not consistently stable across periods. This volatility weakens confidence that internally generated funds can reliably support operations and growth.

PuraPharm Corp. Ltd. News

1498 FAQ

What was PuraPharm Corp. Ltd.’s price range in the past 12 months?
PuraPharm Corp. Ltd. lowest stock price was HK$0.21 and its highest was HK$0.41 in the past 12 months.
What is PuraPharm Corp. Ltd.’s market cap?
PuraPharm Corp. Ltd.’s market cap is HK$127.85M.
When is PuraPharm Corp. Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were PuraPharm Corp. Ltd.’s earnings last quarter?
PuraPharm Corp. Ltd. released its earnings results on Aug 26, 2026. The company reported -HK$0.027 earnings per share for the quarter.
Is PuraPharm Corp. Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does PuraPharm Corp. Ltd. pay dividends?
PuraPharm Corp. Ltd. pays an annual dividend of HK$0.019 which represents an annual dividend yield of ―. See more information on PuraPharm Corp. Ltd. dividends here
What is PuraPharm Corp. Ltd.’s EPS estimate?
PuraPharm Corp. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PuraPharm Corp. Ltd. have?
PuraPharm Corp. Ltd. has 535,897,640 shares outstanding.
What happened to PuraPharm Corp. Ltd.’s price movement after its last earnings report?
PuraPharm Corp. Ltd. reported an EPS of -HK$0.027 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of PuraPharm Corp. Ltd.?
Currently, no hedge funds are holding shares in HK:1498
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology